D.P. Deakin

1.6k total citations
40 papers, 1.2k citations indexed

About

D.P. Deakin is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D.P. Deakin has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 17 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D.P. Deakin's work include Lymphoma Diagnosis and Treatment (26 papers), Viral-associated cancers and disorders (13 papers) and Lung Cancer Treatments and Mutations (11 papers). D.P. Deakin is often cited by papers focused on Lymphoma Diagnosis and Treatment (26 papers), Viral-associated cancers and disorders (13 papers) and Lung Cancer Treatments and Mutations (11 papers). D.P. Deakin collaborates with scholars based in United Kingdom, United States and Netherlands. D.P. Deakin's co-authors include G.R. Morgenstern, D. Crowther, Stephen M. Shalet, John Radford, Martin Harris, J.H. Scarffe, Ian Todd, P M Wilkinson, John Wagstaff and William P. Steward and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

D.P. Deakin

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.P. Deakin United Kingdom 21 755 449 294 284 236 40 1.2k
W S Velasquez United States 16 845 1.1× 670 1.5× 229 0.8× 367 1.3× 238 1.0× 17 1.3k
Astrid Franke Germany 13 641 0.8× 403 0.9× 154 0.5× 392 1.4× 143 0.6× 28 1.0k
S Pavlovsky Argentina 21 569 0.8× 585 1.3× 277 0.9× 265 0.9× 236 1.0× 81 1.4k
Agustín Avilés Mexico 24 1.2k 1.6× 1.0k 2.3× 245 0.8× 293 1.0× 410 1.7× 114 1.9k
P Grozea United States 12 1.1k 1.4× 889 2.0× 337 1.1× 385 1.4× 366 1.6× 28 1.6k
J R Anderson United States 13 881 1.2× 603 1.3× 114 0.4× 261 0.9× 170 0.7× 21 1.3k
B. Vaughan Hudson United Kingdom 24 1.5k 2.1× 830 1.8× 522 1.8× 451 1.6× 377 1.6× 36 1.9k
Natividad Neri Mexico 22 893 1.2× 952 2.1× 226 0.8× 181 0.6× 224 0.9× 70 1.6k
CW Berard United States 22 1.2k 1.6× 672 1.5× 228 0.8× 428 1.5× 417 1.8× 34 1.7k
S.B. Sutcliffe United Kingdom 9 1.3k 1.8× 663 1.5× 400 1.4× 313 1.1× 441 1.9× 12 1.7k

Countries citing papers authored by D.P. Deakin

Since Specialization
Citations

This map shows the geographic impact of D.P. Deakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.P. Deakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.P. Deakin more than expected).

Fields of papers citing papers by D.P. Deakin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.P. Deakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.P. Deakin. The network helps show where D.P. Deakin may publish in the future.

Co-authorship network of co-authors of D.P. Deakin

This figure shows the co-authorship network connecting the top 25 collaborators of D.P. Deakin. A scholar is included among the top collaborators of D.P. Deakin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.P. Deakin. D.P. Deakin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howell, Sacha J., James Chang, G.R. Morgenstern, et al.. (2002). The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. British Journal of Haematology. 119(2). 408–411. 69 indexed citations
2.
Rohatiner, A. Z. S., John Radford, D.P. Deakin, et al.. (2001). A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma. British Journal of Cancer. 85(1). 29–35. 34 indexed citations
3.
4.
Shamash, Jonathan, Siow Ming Lee, John Radford, et al.. (2000). Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study. Annals of Oncology. 11(6). 715–719. 26 indexed citations
5.
Perrin, B., et al.. (2000). Investigation of dose homogeneity in paediatric anthropomorphic phantoms for a simple total body irradiation technique.. British Journal of Radiology. 73(867). 317–321. 2 indexed citations
6.
Wylie, J., et al.. (2000). A Doxorubicin-Based Regimen used in the Treatment of Elderly Patients with High-Grade Non-Hodgkin's Lymphoma. Clinical Oncology. 12(3). 153–157. 1 indexed citations
7.
Bainbridge, David R.J., D.P. Deakin, & Henry N. Jabbour. (1998). Premature Luteal Regression Induced by Equine Chorionic Gonadotropin and Estrogen is Suppressed by Administration of Exogenous Interferon in Red Deer (Cervus Elaphus)1. Biology of Reproduction. 58(1). 124–129. 7 indexed citations
8.
Wylie, James, Richard Cowan, & D.P. Deakin. (1998). The role of radiotherapy in the treatment of localised intermediate and high grade non-Hodgkin's lymphoma in elderly patients. Radiotherapy and Oncology. 49(1). 9–14. 7 indexed citations
9.
Pettengell, Ruth, John Radford, G.R. Morgenstern, et al.. (1996). Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 14(2). 586–592. 69 indexed citations
10.
Radford, John, D Crowther, A. Z. S. Rohatiner, et al.. (1995). Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.. Journal of Clinical Oncology. 13(9). 2379–2385. 35 indexed citations
11.
Pettengell, Ruth, et al.. (1992). Peripheral blood progenitor cells PBPC for haemopoietic rescue for poor prognosis high grade NHL. Research Explorer (The University of Manchester). 33. 1 indexed citations
12.
Ranson, Malcolm, John Radford, R. Swindell, et al.. (1991). An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP. Annals of Oncology. 2(6). 423–430. 9 indexed citations
13.
14.
Price, C. G. A., A. Z. S. Rohatiner, William P. Steward, et al.. (1991). Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: Preliminary results of a randomized trial in progress. European Journal of Cancer and Clinical Oncology. 27. S34–S36. 12 indexed citations
15.
Price, C. G. A., A. Z. S. Rohatiner, William P. Steward, et al.. (1991). Interferon-α2b in the treatment of follicular lymphoma: Preliminary results of a trial in progress. Annals of Oncology. 2 Suppl 2. 141–145. 42 indexed citations
16.
Ranson, Malcolm, J H Scarffe, G.R. Morgenstern, et al.. (1991). Post consolidation therapy for adult patients with acute myeloid leukaemia. British Journal of Haematology. 79(2). 162–169. 2 indexed citations
17.
Radford, John, et al.. (1990). VAPEC B: a weekly chemotherapy for high grade non-Hodgkin's lymphoma. Early results of a collaborative trial at two centres.. UCL Discovery (University College London). 1 indexed citations
18.
Cowan, Richard, et al.. (1988). 114Inm oxine-labelled lymphocytes —therapeutic applications. Nuclear Medicine Communications. 9(10). 797–802. 1 indexed citations
19.
Slevin, N.J., B. Oppenheim, & D.P. Deakin. (1988). Aeromonas hydrophila septicaemia and muscle abscesses associated with immunosuppression. Postgraduate Medical Journal. 64(755). 701–702. 5 indexed citations
20.
Ahmed, S R, Stephen M. Shalet, R. H. A. Campbell, & D.P. Deakin. (1983). Primary gonadal damage following treatment of brain tumors in childhood. The Journal of Pediatrics. 103(4). 562–565. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W S Velasquez Breakdown of academic impact, for papers by Astrid Franke Breakdown of academic impact, for papers by S Pavlovsky Breakdown of academic impact, for papers by Agustín Avilés Breakdown of academic impact, for papers by P Grozea Breakdown of academic impact, for papers by J R Anderson Breakdown of academic impact, for papers by B. Vaughan Hudson Breakdown of academic impact, for papers by Natividad Neri Breakdown of academic impact, for papers by CW Berard Breakdown of academic impact, for papers by S.B. Sutcliffe
Rankless by CCL
2026